Synchrony Financial
SYF
$79.47
+3.60%
Synchrony Financial is the largest provider of private-label credit cards in the United States, offering retail credit cards, promotional financing, and healthcare credit solutions through partnerships with merchants and healthcare providers. As a dominant player in the consumer credit space, it leverages its scale and data analytics to drive purchase volume and receivables growth. The current investor narrative centers on improving credit metrics and consumer resilience despite inflationary pressures, alongside a robust capital return program that includes significant share buybacks. Recent headlines highlight improving credit numbers and a $900 million stock repurchase in Q1 2026, reinforcing management's confidence in the company's financial strength and undervaluation.…
SYF
Synchrony Financial
$79.47
Related headlines
Investment Opinion: Should I buy SYF Today?
Synchrony is rated a Buy based on its attractive valuation, strong revenue growth, and robust capital returns. The consensus recommendation is Buy with an average target of $89.09, implying 10% upside. The stock trades at a trailing PE of 8.92x, a 40.5% discount to the industry average of 15x, and a forward PE of 7.71x, indicating expected earnings growth. Revenue grew 16.6% YoY in Q1 2026, and the company has a net margin of 14.4% and ROE of 21.2%, demonstrating profitability. Free cash flow of $9.834B supports buybacks and dividends, with a yield of 1.71%.
Sign up to view all
SYF 12-Month Price Forecast
The AI assessment is bullish, driven by Synchrony's strong revenue acceleration, undervaluation relative to peers, and robust capital returns. The improving credit metrics and high ROE support the thesis, but the medium confidence reflects the risks from high leverage and margin volatility. The stance would upgrade to high confidence if revenue growth sustains above 15% and margins stabilize, while a downgrade to neutral would occur if credit costs rise significantly or the stock's PE exceeds 10x.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synchrony Financial's 12-month outlook, with a consensus price target around $89.09 and implied upside of +12.1% versus the current price.
Average Target
$89.09
0 analysts
Implied Upside
+12.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $104
Analyst target range
Synchrony is covered by 23 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 1.875 (where 1 is Strong Buy and 5 is Sell). The average target price is $89.09, implying a 10.0% upside from the current price of $81.00. The distribution includes 10 Buy ratings, 8 Hold ratings, and 5 Sell ratings, indicating a moderately bullish stance. The low target of $78.00 suggests a 3.7% downside, while the high target of $104.00 implies a 28.4% upside. The wide spread between low and high targets (26 points) reflects uncertainty about consumer credit conditions and interest rate impacts. Recent ratings actions include HSBC reiterating Buy, JP Morgan maintaining Neutral, and BTIG downgrading from Buy to Neutral, indicating mixed sentiment but overall positive outlook.
Bulls vs Bears: SYF Investment Factors
Synchrony presents a compelling value proposition with strong revenue growth, aggressive buybacks, and a PE discount to peers, but faces risks from high leverage, declining margins, and consumer credit sensitivity. The bull case is supported by improving credit metrics and a 10% upside to analyst targets, while the bear case hinges on margin compression and macro headwinds. Currently, the bull evidence is slightly stronger given the revenue acceleration and capital return program, but the key tension is whether the improving credit trends can offset margin pressures. If credit metrics continue to improve, the stock could re-rate higher; if not, the low valuation may be justified.
Bullish
- Strong Revenue Acceleration: Q1 2026 revenue surged 16.6% YoY to $5.603B, up from $4.766B in Q4 2025, marking a sharp acceleration after a slight dip. This growth is driven by higher purchase volumes and receivables, indicating robust consumer spending and successful merchant partnerships.
- Undervalued with 10% Upside: Trading at $81.00, the stock has a 10.0% upside to the average analyst target of $89.09, with a high target of $104.00 implying 28.4% upside. The trailing PE of 8.92x is a 40.5% discount to the industry average of 15x, suggesting the market is not fully pricing in its earnings power.
- Aggressive Capital Returns: Synchrony repurchased $900M of stock in Q1 2026, signaling management's confidence in undervaluation. The payout ratio is 14.4% with a dividend yield of 1.71%, and the company has a strong track record of returning capital to shareholders, which supports EPS growth.
- Improving Credit Metrics: Recent news highlights improving credit numbers despite inflation, indicating consumer resilience. This is critical for a lender, as lower delinquencies and charge-offs reduce credit costs and boost profitability, as seen in the 82.7% gross margin in Q1 2026.
Bearish
- High Beta and Market Sensitivity: With a beta of 1.311, Synchrony is more volatile than the market, amplifying downturns. The stock's 1-year relative strength of -9.15% vs. S&P 500 indicates underperformance, and a 27.91% max drawdown over the past year highlights significant downside risk.
- Mixed Analyst Sentiment: While the consensus is Buy, 8 analysts rate it Hold and 5 rate it Sell, with a mean score of 1.875. Recent actions include BTIG downgrading to Neutral, reflecting uncertainty about consumer credit and interest rates. The low target of $78.00 implies a 3.7% downside.
- Declining Net Margin Trend: Net margin fell from 22.3% in Q3 2025 to 14.4% in Q1 2026, a significant drop. This decline, driven by higher provisions for credit losses and operating expenses, could pressure earnings if the trend continues, despite revenue growth.
- High Debt Levels: The debt-to-equity ratio of 0.91 and current ratio of 0.21 indicate high leverage and low liquidity. This financial structure increases vulnerability to rising interest rates or economic downturns, as interest expenses (e.g., $968M in Q1 2026) consume a significant portion of revenue.
SYF Technical Analysis
Synchrony Financial's stock is in a clear recovery uptrend, with a 1-year price change of +11.2% and a 3-month change of +13.5%. The current price of $81.00 sits at 91.3% of its 52-week range (between $63.08 low and $88.77 high), indicating strong momentum and proximity to recent highs. This positioning suggests bullish sentiment, though the stock remains below its 52-week high, leaving room for potential resistance. The 6-month change of +13.5% aligns with the 3-month figure, indicating consistent upward movement over the past half-year, while the YTD change of -4.3% reflects earlier weakness that has since been recovered.
Beta
1.31
1.31x market volatility
Max Drawdown
-27.9%
Largest decline past year
52-Week Range
$63-$89
Price range past year
Annual Return
+11.6%
Cumulative gain past year
| Period | SYF Return | S&P 500 |
|---|---|---|
| 1m | +9.1% | +2.5% |
| 3m | +10.6% | +2.7% |
| 6m | +8.3% | +11.1% |
| 1y | +11.6% | +20.5% |
| ytd | -6.1% | +12.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SYF Fundamental Analysis
Synchrony's revenue trajectory is robust, with Q1 2026 revenue of $5.603 billion, up 16.6% year-over-year, accelerating from the prior quarter's $4.766 billion (which was down 3.1% from Q3 2025's $4.834 billion). The multi-quarter trend shows revenue growing from $4.712 billion in Q2 2025 to $5.603 billion in Q1 2026, indicating a strong rebound. Net income for Q1 2026 was $805 million, with a net margin of 14.4%, down from 22.3% in Q3 2025 but up from 15.8% in Q4 2025. Gross margin improved to 82.7% in Q1 2026, up from 49.3% in Q4 2025, reflecting lower cost of revenue. The company is highly profitable, with EPS of $2.29 in Q1 2026, and operating margin of 16.3%.
Quarterly Revenue
$5.6B
2026-03
Revenue YoY Growth
+16.6%
YoY Comparison
Gross Margin
82.7%
Latest Quarter
Free Cash Flow
$9.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SYF Overvalued?
Given Synchrony's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 8.92x, while the forward PE is 7.71x, indicating the market expects earnings growth. The gap between trailing and forward PE suggests a 13.6% expected increase in earnings, which is modest but positive. Compared to the industry average PE of 15x (estimated), Synchrony trades at a 40.5% discount, reflecting its lower valuation despite strong profitability. Historically, the stock's PE has ranged from 3.29x (Q1 2024) to 10.08x (Q4 2025), with the current 8.92x near the higher end, suggesting the market is pricing in optimistic expectations. The PEG ratio of 1.09 indicates the stock is fairly valued relative to its growth rate.
PE
8.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~10x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Synchrony carries a debt-to-equity ratio of 0.91, indicating substantial leverage that amplifies earnings volatility. Interest expenses of $968M in Q1 2026 represent 17.3% of revenue, and the current ratio of 0.21 suggests limited short-term liquidity, though the company generates strong free cash flow of $9.834B TTM. Net margin has declined from 22.3% in Q3 2025 to 14.4% in Q1 2026, reflecting higher credit costs and operating expenses, which could pressure future earnings if not reversed. The payout ratio of 14.4% is conservative, but the high leverage increases vulnerability to interest rate hikes, which could raise borrowing costs and reduce net income.
FAQ
The key risks include: 1) Financial risk from high leverage (debt-to-equity of 0.91) and declining net margins (14.4% in Q1 2026 vs. 22.3% in Q3 2025). 2) Market risk from high beta (1.311) and underperformance vs. S&P 500 (1-year relative strength -9.15%). 3) Credit risk from potential consumer defaults if the economy weakens, which could increase loan loss provisions. 4) Regulatory risk from changes in consumer credit laws. The most severe risk is a recession leading to a -22% drop to the 52-week low of $63.08.
The 12-month forecast is moderately bullish, with a base case probability of 50% targeting $85-$92, aligning with the average analyst target of $89.09. The bull case (30% probability) targets $95-$104, driven by strong growth and margin expansion, while the bear case (20% probability) targets $63-$78, if credit conditions deteriorate. The most likely scenario is the base case, assuming stable consumer credit and continued revenue growth. The stock is expected to provide a 10% return in the next year.
Synchrony is undervalued relative to its peers, trading at a trailing PE of 8.92x versus the industry average of 15x, a 40.5% discount. Its forward PE of 7.71x suggests expected earnings growth, and the PEG ratio of 1.09 indicates fair value relative to growth. Historically, the stock's PE has ranged from 3.29x to 10.08x, so the current level is near the higher end, but still below the industry. The market is pricing in modest growth and some credit risk, but the valuation appears attractive for the fundamentals.
Synchrony is a good buy for investors seeking value and growth, given its 10% upside to the average analyst target of $89.09 and a trailing PE of 8.92x, which is a 40.5% discount to the industry average. The stock offers a dividend yield of 1.71% and benefits from aggressive buybacks. However, it carries high leverage and is sensitive to consumer credit, so it's best for investors with a higher risk tolerance. If you believe consumer credit will remain stable, the risk/reward is favorable.
Synchrony is suitable for long-term investment, given its strong market position, high ROE of 21.2%, and consistent capital returns. The stock's beta of 1.311 makes it volatile in the short term, but over a 3-5 year horizon, the low valuation and growth potential should drive returns. The dividend yield of 1.71% provides income, and the buyback program supports EPS growth. For short-term traders, the stock offers opportunities due to its volatility, but the fundamental thesis is best realized over the long term. A minimum holding period of 3 years is recommended to ride out credit cycles.